Roadmapping as a Tool for Renewing Regulatory Practices

The Case of Stem Cells

Kristian Borch, Jesper Norus

Research output: Working paperResearch

Abstract

The aim of this paper is to explore technological roadmaps to identify key issues concerning the development and utilization of stem cells. From a review of the political decision making processes in three countries, Denmark, the Netherlands, and Germany we suggest that technological roadmapping in this emerging and discontinued technology can provide critical policy information. This type of policy intelligence can be used to rethink the regulatory practices away from today’s framework based regulation of the emerging technologies towards a regulatory policy based on how to develop regulatory practices based on the content and visions of the technologies in question. In the conclusion we discuss that the positive side effect of such a shift in the regulatory paradigm is that technological roadmapping can be used as a planning tool to deal with priorities in the health care system when the technologies are in its embryonic stage.
Original languageEnglish
Place of PublicationFrederiksberg
PublisherResearch Centre on Biotech Business, CBS
Number of pages16
ISBN (Print)8791549043
Publication statusPublished - 2004

Keywords

  • Stem cell technologies
  • Roadmap
  • S&T policy

Cite this

Borch, K., & Norus, J. (2004). Roadmapping as a Tool for Renewing Regulatory Practices: The Case of Stem Cells. Frederiksberg: Research Centre on Biotech Business, CBS.
Borch, Kristian ; Norus, Jesper. / Roadmapping as a Tool for Renewing Regulatory Practices : The Case of Stem Cells. Frederiksberg : Research Centre on Biotech Business, CBS, 2004.
@techreport{972ee7e08eb511dba124000ea68e967b,
title = "Roadmapping as a Tool for Renewing Regulatory Practices: The Case of Stem Cells",
abstract = "The aim of this paper is to explore technological roadmaps to identify key issues concerning the development and utilization of stem cells. From a review of the political decision making processes in three countries, Denmark, the Netherlands, and Germany we suggest that technological roadmapping in this emerging and discontinued technology can provide critical policy information. This type of policy intelligence can be used to rethink the regulatory practices away from today’s framework based regulation of the emerging technologies towards a regulatory policy based on how to develop regulatory practices based on the content and visions of the technologies in question. In the conclusion we discuss that the positive side effect of such a shift in the regulatory paradigm is that technological roadmapping can be used as a planning tool to deal with priorities in the health care system when the technologies are in its embryonic stage.",
keywords = "Genteknologi, Bioteknologi, Stem cell technologies, Roadmap, S&T policy, Stem cell technologies, Roadmap, S&T policy",
author = "Kristian Borch and Jesper Norus",
year = "2004",
language = "English",
isbn = "8791549043",
publisher = "Research Centre on Biotech Business, CBS",
type = "WorkingPaper",
institution = "Research Centre on Biotech Business, CBS",

}

Borch, K & Norus, J 2004 'Roadmapping as a Tool for Renewing Regulatory Practices: The Case of Stem Cells' Research Centre on Biotech Business, CBS, Frederiksberg.

Roadmapping as a Tool for Renewing Regulatory Practices : The Case of Stem Cells. / Borch, Kristian; Norus, Jesper.

Frederiksberg : Research Centre on Biotech Business, CBS, 2004.

Research output: Working paperResearch

TY - UNPB

T1 - Roadmapping as a Tool for Renewing Regulatory Practices

T2 - The Case of Stem Cells

AU - Borch, Kristian

AU - Norus, Jesper

PY - 2004

Y1 - 2004

N2 - The aim of this paper is to explore technological roadmaps to identify key issues concerning the development and utilization of stem cells. From a review of the political decision making processes in three countries, Denmark, the Netherlands, and Germany we suggest that technological roadmapping in this emerging and discontinued technology can provide critical policy information. This type of policy intelligence can be used to rethink the regulatory practices away from today’s framework based regulation of the emerging technologies towards a regulatory policy based on how to develop regulatory practices based on the content and visions of the technologies in question. In the conclusion we discuss that the positive side effect of such a shift in the regulatory paradigm is that technological roadmapping can be used as a planning tool to deal with priorities in the health care system when the technologies are in its embryonic stage.

AB - The aim of this paper is to explore technological roadmaps to identify key issues concerning the development and utilization of stem cells. From a review of the political decision making processes in three countries, Denmark, the Netherlands, and Germany we suggest that technological roadmapping in this emerging and discontinued technology can provide critical policy information. This type of policy intelligence can be used to rethink the regulatory practices away from today’s framework based regulation of the emerging technologies towards a regulatory policy based on how to develop regulatory practices based on the content and visions of the technologies in question. In the conclusion we discuss that the positive side effect of such a shift in the regulatory paradigm is that technological roadmapping can be used as a planning tool to deal with priorities in the health care system when the technologies are in its embryonic stage.

KW - Genteknologi

KW - Bioteknologi

KW - Stem cell technologies

KW - Roadmap

KW - S&T policy

KW - Stem cell technologies

KW - Roadmap

KW - S&T policy

M3 - Working paper

SN - 8791549043

BT - Roadmapping as a Tool for Renewing Regulatory Practices

PB - Research Centre on Biotech Business, CBS

CY - Frederiksberg

ER -

Borch K, Norus J. Roadmapping as a Tool for Renewing Regulatory Practices: The Case of Stem Cells. Frederiksberg: Research Centre on Biotech Business, CBS. 2004.